These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25917672)

  • 1. Methods and challenges in measuring the impact of national pneumococcal and rotavirus vaccine introduction on morbidity and mortality in Malawi.
    Bar-Zeev N; Kapanda L; King C; Beard J; Phiri T; Mvula H; Crampin AC; Mwansambo C; Costello A; Parashar U; Tate JE; Verani JR; Whitney CG; Heyderman RS; Cunliffe NA; French N;
    Vaccine; 2015 May; 33(23):2637-45. PubMed ID: 25917672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The composition of demand for newly launched vaccines: results from the pneumococcal and rotavirus vaccine introductions in Ethiopia and Malawi.
    Williams BA; Kidane T; Chirwa G; Tesfaye N; Prescott MR; Scotney ST; Valle M; Abebe S; Tambuli A; Malewezi B; Mohammed T; Kobayashi E; Wootton E; Wong R; Dosani R; Subramaniam H; Joseph J; Yavuz E; Apple A; Le Tallec Y; Kang'ethe A
    Health Policy Plan; 2016 Jun; 31(5):563-72. PubMed ID: 26856361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodological challenges in measuring vaccine effectiveness using population cohorts in low resource settings.
    King C; Beard J; Crampin AC; Costello A; Mwansambo C; Cunliffe NA; Heyderman RS; French N; Bar-Zeev N;
    Vaccine; 2015 Sep; 33(38):4748-55. PubMed ID: 26235370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme.
    Madhi SA; Bamford L; Ngcobo N
    S Afr Med J; 2014 Mar; 104(3 Suppl 1):228-34. PubMed ID: 24893498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of uptake of newly introduced vaccines in Malawi - monovalent human rotavirus and pneumococcal conjugate vaccines: Evidence from the 2015-16 Malawi demographic and health survey.
    Ntenda PAM; Mwenyenkulu ET; Putthanachote N; Nkoka O; Mhone TG; Motsa MPS; Tizifa T
    J Trop Pediatr; 2019 Jun; 65(3):287-296. PubMed ID: 30085260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study.
    Bar-Zeev N; Kapanda L; Tate JE; Jere KC; Iturriza-Gomara M; Nakagomi O; Mwansambo C; Costello A; Parashar UD; Heyderman RS; French N; Cunliffe NA;
    Lancet Infect Dis; 2015 Apr; 15(4):422-8. PubMed ID: 25638521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in Children in Chile: A Nested Case-Control Study Using Nationwide Pneumonia Morbidity and Mortality Surveillance Data.
    Diaz J; Terrazas S; Bierrenbach AL; Toscano CM; Alencar GP; Alvarez A; Valenzuela MT; Andrus J; del Aguila R; Hormazábal JC; Araya P; Pidal P; Matus CR; de Oliveira LH
    PLoS One; 2016; 11(4):e0153141. PubMed ID: 27058873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda.
    Tate JE; Kisakye A; Mugyenyi P; Kizza D; Odiit A; Braka F
    Vaccine; 2011 Apr; 29(17):3329-34. PubMed ID: 21241733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The worldwide impact of the seven-valent pneumococcal conjugate vaccine.
    Fitzwater SP; Chandran A; Santosham M; Johnson HL
    Pediatr Infect Dis J; 2012 May; 31(5):501-8. PubMed ID: 22327872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population impact and effectiveness of sequential 13-valent pneumococcal conjugate and monovalent rotavirus vaccine introduction on infant mortality: prospective birth cohort studies from Malawi.
    King C; Bar-Zeev N; Phiri T; Beard J; Mvula H; Crampin A; Heinsbroek E; Hungerford D; Lewycka S; Verani J; Whitney C; Costello A; Mwansambo C; Cunliffe N; Heyderman R; French N;
    BMJ Glob Health; 2020 Sep; 5(9):. PubMed ID: 32912855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocontribution of Rotavirus and Pneumococcal Conjugate Vaccines to the Reduction of Pediatric Hospital Visits in Young Children.
    Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
    J Pediatr; 2017 Mar; 182():253-259.e2. PubMed ID: 27939127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of pneumococcal disease through vaccination.
    Gentile A; Bazán V
    Vaccine; 2011 Sep; 29 Suppl 3():C15-25. PubMed ID: 21896348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ecological assessment of the direct and indirect effects of routine rotavirus vaccination in Merseyside, UK using data from multiple health systems: a study protocol.
    Hungerford D; Vivancos R; French N; Iturriza-Gomara M; Cunliffe N
    BMJ Open; 2014 Nov; 4(11):e006161. PubMed ID: 25424995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population based study comparing changes in rotavirus burden on the Island of Ireland between a highly vaccinated population and an unvaccinated population.
    Armstrong G; Gallagher N; Cabrey P; Graham AM; McKeown PJ; Jackson S; Dallat M; Smithson RD
    Vaccine; 2016 Sep; 34(39):4718-4723. PubMed ID: 27527819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the costs of implementing the rotavirus vaccine in the national immunisation programme: the case of Malawi.
    Madsen LB; Ustrup M; Hansen KS; Nyasulu PS; Bygbjerg IC; Konradsen F
    Trop Med Int Health; 2014 Feb; 19(2):177-85. PubMed ID: 24314006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction.
    Valcarcel Salamanca B; Hagerup-Jenssen ME; Flem E
    Vaccine; 2016 Sep; 34(39):4684-4689. PubMed ID: 27522178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghana and Rwanda expand national immunization programs.
    Riedmann EM
    Hum Vaccin Immunother; 2012 Jul; 8(7):848. PubMed ID: 23213664
    [No Abstract]   [Full Text] [Related]  

  • 19. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.
    Tate JE; Patel MM; Cortese MM; Lopman BA; Gentsch JR; Fleming J; Steele AD; Parashar UD
    Expert Rev Vaccines; 2012 Feb; 11(2):211-20. PubMed ID: 22309669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana.
    Enane LA; Gastañaduy PA; Goldfarb DM; Pernica JM; Mokomane M; Moorad B; Masole L; Tate JE; Parashar UD; Steenhoff AP
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S168-74. PubMed ID: 27059352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.